Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Profit After Tax (PAT) Margin

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Profit After Tax (PAT) Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PAT Margin (%) 3.57-6.61-0.323.573.84

What is the latest Profit After Tax (PAT) Margin ratio of GLENMARK PHARMACEUTICALS ?

The latest Profit After Tax (PAT) Margin ratio of GLENMARK PHARMACEUTICALS is 3.57 based on Mar2025 Consolidated results.
Year Profit After Tax (PAT) Margin
Mar20253.57
Mar2024-6.61
Mar2023-0.32
Mar20223.57
Mar20213.84

How is Profit After Tax (PAT) Margin of GLENMARK PHARMACEUTICALS Trending?

Years Profit After Tax (PAT) Margin % Change
Mar2025 3.57
Positive
Mar2024 -6.61
Negative
Mar2023 -0.32
Negative
Mar2022 3.57
-7.03
Mar2021 3.84 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Profit After Tax (PAT) Margin ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,324.7 Cr 3.8% 1.5% 31.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -0.5% 1.8% -2% Stock Analytics
DIVIS LABORATORIES ₹163,363.0 Cr -0.3% -1.3% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,193.0 Cr 4.4% 6% 27.7% Stock Analytics
CIPLA ₹109,519.0 Cr 1% -3% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,940.0 Cr 1.1% 8% 3.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.8%

1.5%

31.9%

SENSEX

-0.9%

-0.1%

7%


You may also like the below Video Courses